Juno uses lethal neurotox lessons to guide Goldilocks formula for its next-gen CAR-T
WASHINGTON, DC — Neurotoxicity killed JCAR015 right along with 5 patients in the lead pivotal study, derailing Juno Therapeutics $JUNO and allowing first Novartis …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.